Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
SQNS - Sequans Communications S.A ADR - Stock Price Chart
TickerSQNS [NYSE]
CompanySequans Communications S.A ADR
CountryFrance
IndustrySemiconductors
Market Cap55.50MEPS (ttm)-
P/E-EPS this Y-175.00%
Forward P/E30.00EPS next Y109.09%
PEG-EPS past 5Y31.84%
P/S1.24EPS next 5Y0.35%
P/B6.19EPS Q/Q-
Dividend-Sales Q/Q-53.14%
Insider Own5.36%Inst Own57.86%
Insider Trans0.00%Inst Trans1.46%
Short Float0.08%EarningsNov 02/b
Analyst Recom1.00Target Price12.12
Avg Volume118.21K52W Range1.86 - 2.97
Sequans Communications SA engages in the design, development, and supply of cellular semiconductor solutions for the broadband and Internet of Things (IoT) markets. The firm offers 5G and 4G chips and modules for non-smartphone devices. Its products and solutions include chips, modules, development kits, and custom technology solutions. The company was founded by Georges Karam and Bertrand Debray in September 2003 and is headquartered in Colombes, France.
CPOP - Pop Culture Group Co Ltd - Stock Price Chart
TickerCPOP [NASD]
CompanyPop Culture Group Co Ltd
CountryChina
IndustryEntertainment
Market Cap9.13MEPS (ttm)-1.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.49EPS next 5Y-
P/B3.36EPS Q/Q-5843.66%
Dividend-Sales Q/Q-39.94%
Insider Own46.04%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume2.50M52W Range0.91 - 10.90
Pop Culture Group Co., Ltd. engages in developing and hosting hip-hop events. It provides brand promotion services, such as trademark and logo design, visual identity system design, brand positioning, brand personality design, and digital solution and other services as advertisement distribution to corporate clients. The company was founded in 2007 and is headquartered in Xiamen, China.
HOLO - MicroCloud Hologram Inc - Stock Price Chart
TickerHOLO [NASD]
CompanyMicroCloud Hologram Inc
CountryUSA
IndustryElectronic Components
Market Cap39.26MEPS (ttm)-0.82
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.90EPS next 5Y-
P/B1.42EPS Q/Q-320.24%
Dividend-Sales Q/Q-
Insider Own81.30%Inst Own0.18%
Insider Trans0.00%Inst Trans-
Short Float4.48%Earnings-
Analyst Recom-Target Price-
Avg Volume4.89M52W Range1.50 - 113.00
MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.
MODV - ModivCare Inc - Stock Price Chart
TickerMODV [NASD, RUT]
CompanyModivCare Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap377.74MEPS (ttm)-14.43
P/E-EPS this Y2.75%
Forward P/E4.36EPS next Y6.08%
PEG-EPS past 5Y-49.24%
P/S0.14EPS next 5Y6.99%
P/B2.38EPS Q/Q24.74%
Dividend-Sales Q/Q7.48%
Insider Own1.68%Inst Own102.35%
Insider Trans370.17%Inst Trans-5.14%
Short Float5.96%EarningsFeb 22/a
Analyst Recom1.80Target Price62.60
Avg Volume120.88K52W Range26.05 - 107.12
Feb-23-24Downgrade Jefferies Buy → Hold $60 → $39
Feb-23-24Downgrade Deutsche Bank Buy → Hold $60 → $40
ModivCare, Inc. is a technology-enabled healthcare services company, which engages in the provision of a suite of integrated supportive care solutions for public and private payors and their members. It operates through the following segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other. The NEMT segment is involved in the non-emergency medical transportation programs for state governments and managed care organizations, or MCOs, in the U.S. The Personal Care segment offers home personal care services to State and Managed Medicaid, Medicare, and Private Pay patient populations in need of care monitoring and assistance performing activities of daily living. The RPM segment focuses on remote patient monitoring solutions, including personal emergency response systems, vitals monitoring, and data-driven patient engagement solutions. The Corporate and Other segment includes the costs associated with the company's corporate operations. The company was founded by Fletcher Jay McCusker in December 1996 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coliseum Capital Management, LDirectorFeb 16Option Exercise0.001,31402,984,065Feb 20 04:24 PM
Coliseum Capital Management, LDirectorSep 15Buy35.00204,3797,153,4412,982,751Sep 15 08:14 PM
Sampson L HeathPresident, CEOSep 15Buy34.573,500121,00927,966Sep 19 04:15 PM
Coliseum Capital Management, LDirectorSep 13Buy29.11125,8373,663,3892,778,372Sep 15 08:14 PM
Coliseum Capital Management, LDirectorSep 12Buy28.5079,7262,272,1912,652,535Sep 13 04:15 PM
UPLD - Upland Software Inc - Stock Price Chart
TickerUPLD [NASD]
CompanyUpland Software Inc
CountryUSA
IndustrySoftware - Application
Market Cap88.52MEPS (ttm)-5.76
P/E-EPS this Y-44.33%
Forward P/E4.57EPS next Y14.20%
PEG-EPS past 5Y-60.49%
P/S0.30EPS next 5Y-
P/B0.67EPS Q/Q25.42%
Dividend-Sales Q/Q-8.42%
Insider Own17.79%Inst Own79.56%
Insider Trans-0.61%Inst Trans2.61%
Short Float1.99%EarningsFeb 22/a
Analyst Recom2.67Target Price4.67
Avg Volume196.42K52W Range2.42 - 8.81
Upland Software, Inc. engages in providing cloud-based software applications. Its products include AccuRoute, Adestra, Altify, BA Insight, Cimpl, ComSci, Eclipse PPM, FileBound, InGenius, Intelligent Capture, InterFAX, Kapost, Localytics, Mobile Commons, Objectif Lune, Panviva, PostUp, PowerStreering, PSA, Qvidian, Rant and Rave, RightAnswers, RO Innovation, Second Street, Ultriva, and Waterfall. The company was founded by John T. McDonald in July 2010 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COURTER STEPHEN EDirectorNov 21Sale4.4320,44890,62674,232Nov 22 03:27 PM
Doman DanChief Product OfficerNov 07Sale4.8013,99667,242199,779Nov 09 04:50 PM
MCDONALD JOHN TCEOMar 13Buy4.7510,00047,500263,738Mar 14 04:08 PM
MCDONALD JOHN TCEOMar 10Buy4.8010,00048,000253,738Mar 14 04:08 PM
ARIZ - Arisz Acquisition Corp - Stock Price Chart
TickerARIZ [NASD]
CompanyArisz Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap37.98MEPS (ttm)0.16
P/E44.74EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.33EPS Q/Q-18.57%
Dividend-Sales Q/Q-
Insider Own34.99%Inst Own63.86%
Insider Trans0.00%Inst Trans-0.60%
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume38.03K52W Range10.25 - 11.95
Arisz Acquisition Corp. is a blank check company, which engages in acquisition, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar combination, with one or more operating businesses. The company was founded on July 21, 2021 and is headquartered in New York, NY.
IBRX - ImmunityBio Inc - Stock Price Chart
TickerIBRX [NASD, RUT]
CompanyImmunityBio Inc
CountryUSA
IndustryBiotechnology
Market Cap2.34BEPS (ttm)-1.05
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y2.79%
P/S4173.19EPS next 5Y-1.70%
P/B-EPS Q/Q30.83%
Dividend-Sales Q/Q-30.51%
Insider Own80.43%Inst Own8.56%
Insider Trans0.00%Inst Trans10.25%
Short Float33.62%Earnings-
Analyst Recom3.00Target Price4.00
Avg Volume3.83M52W Range1.21 - 6.93
Feb-21-24 09:00AM ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial (Business Wire)
Feb-05-24 09:00AM ImmunityBio Quality-of-Life Study in BCG-Unresponsive Bladder Cancer Trial Indicates Improved Physical Function in the 71% Complete Responders Suggesting a Favorable Risk-Benefit Ratio for N-803 Plus BCG (Business Wire)
Jan-02-24 07:10AM ImmunityBio inoculates itself against financial pain, inking $210M royalty deal to get cancer drug to market (FierceBiotech.com)
06:00AM ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million (Business Wire)
Nov-16-23 09:00AM ImmunityBio to Participate in 35th Annual Piper Sandler Healthcare Conference (Business Wire)
Nov-07-23 09:00AM First Data for ImmunityBios Memory Cytokine-Enriched NK Cells in Small Cell Lung Cancer at SITC Meeting Show Promising Anti-tumor Activity (Business Wire)
Oct-26-23 09:00AM FDA Accepts ImmunityBios BLA Resubmission as Complete and Sets New PDUFA Date (Business Wire) +29.75%
Oct-23-23 09:00AM ImmunityBio Announces Biological License Application Resubmission for N-803 in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma-In-Situ (Business Wire) +10.00%
Oct-09-23 08:45AM Lawsuit Notice: Investors who lost money with ImmunityBio, Inc. (NASDAQ: IBRX) shares should contact the Shareholders Foundation (GlobeNewswire)
Sep-11-23 06:00AM ImmunityBio Announces $470 Million Equity and Debt Financing From Founder, Dr. Patrick Soon-Shiong and Nant Entities (Business Wire) +19.38%
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adcock RichardCEO & PresidentFeb 05Option Exercise0.0083,3340286,303Feb 06 09:14 PM
Simon Barry J.DirectorJan 31Option Exercise0.0057,20003,145,855Feb 02 07:38 PM
Sachs David C.Chief Financial OfficerJan 31Option Exercise0.0070,7450212,673Feb 02 07:33 PM
LAUER REGAN JChief Accounting OfficerJan 31Option Exercise0.0032,8720107,804Feb 02 07:32 PM
Adcock RichardCEO & PresidentDec 31Option Exercise0.0034,4830220,065Jan 03 09:40 PM
ICU - SeaStar Medical Holding Corp - Stock Price Chart
TickerICU [NASD]
CompanySeaStar Medical Holding Corp
CountryUSA
IndustryBiotechnology
Market Cap49.98MEPS (ttm)-3.06
P/E-EPS this Y58.93%
Forward P/E-EPS next Y46.96%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-679.79%
Dividend-Sales Q/Q-
Insider Own19.31%Inst Own2.93%
Insider Trans0.80%Inst Trans-0.15%
Short Float2.85%EarningsNov 14/a
Analyst Recom1.00Target Price2.00
Avg Volume5.27M52W Range0.16 - 3.29
Feb-22-24 07:58AM Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune (GlobeNewswire) -23.45%
07:53AM FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney Injury (GlobeNewswire)
Feb-01-24 08:30AM SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology (GlobeNewswire)
Jan-26-24 08:05AM SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) -5.59%
Jan-11-24 04:05PM SeaStar Medical Appoints David A. Green as Chief Financial Officer (GlobeNewswire) -8.41%
Jan-09-24 08:30AM SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications (GlobeNewswire)
Dec-28-23 08:30AM SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury (GlobeNewswire) -5.93%
Dec-13-23 08:30AM SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts (GlobeNewswire)
Nov-14-23 04:04PM SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update (GlobeNewswire)
Oct-31-23 08:00AM Nuwellis' Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device (GlobeNewswire) -17.93%
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Van Heel KennethDirectorNov 22Buy0.40100,00040,000116,400Nov 27 04:05 PM
Chung KevinChief Medical OfficerMay 30Buy0.4712,5435,95368,125Jun 01 04:01 PM
Russell Richard D.DirectorMay 25Buy0.5020,00010,00027,978May 30 04:01 PM
Chung KevinChief Medical OfficerMay 18Buy0.707,5005,24855,582May 22 04:13 PM
AAOI - Applied Optoelectronics Inc - Stock Price Chart
TickerAAOI [NASD]
CompanyApplied Optoelectronics Inc
CountryUSA
IndustryCommunication Equipment
Market Cap502.89MEPS (ttm)-1.79
P/E-EPS this Y77.88%
Forward P/E16.25EPS next Y1037.46%
PEG-EPS past 5Y-74.26%
P/S2.31EPS next 5Y13.00%
P/B2.72EPS Q/Q46.71%
Dividend-Sales Q/Q-1.84%
Insider Own7.66%Inst Own68.89%
Insider Trans-1.51%Inst Trans-2.68%
Short Float23.87%EarningsFeb 22/a
Analyst Recom2.00Target Price18.00
Avg Volume3.37M52W Range1.60 - 24.75
Feb-23-24Downgrade B. Riley Securities Buy → Neutral $22 → $16
Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murry Stefan J.Chief Financial OfficerJan 16Sale17.0820,000341,592200,488Jan 18 04:01 PM
Chang Hung-Lun (Fred)*** See RemarksJan 05Option Exercise13.841,10015,224217,481Jan 09 04:01 PM
Murry Stefan J.Chief Financial OfficerDec 20Option Exercise13.845,00069,200223,815Dec 21 04:01 PM
Yeh Shu-Hua (Joshua)*** See RemarksDec 15Sale23.7120474251,331Dec 18 06:21 PM
Yeh Shu-Hua (Joshua)*** See RemarksDec 14Sale22.3942,779958,023251,351Dec 18 06:21 PM
VERO - Venus Concept Inc - Stock Price Chart
TickerVERO [NASD]
CompanyVenus Concept Inc
CountryCanada
IndustryMedical Devices
Market Cap7.19MEPS (ttm)-6.96
P/E-EPS this Y39.16%
Forward P/E-EPS next Y43.59%
PEG-EPS past 5Y55.10%
P/S0.09EPS next 5Y-
P/B-EPS Q/Q51.13%
Dividend-Sales Q/Q-18.21%
Insider Own41.27%Inst Own15.36%
Insider Trans0.00%Inst Trans-18.85%
Short Float0.86%EarningsNov 14/a
Analyst Recom3.00Target Price10.60
Avg Volume547.07K52W Range0.87 - 4.70
Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.
1234561020